Bevacizumab treatment of symptomatic pseudoprogression after boron neutron capture therapy for recurrent malignant gliomas. Report of 2 cases

BACKGROUND: Bevacizumab, an anti–vascular endothelial growth factor antibody, has been used for the treatment of radiation necrosis. Thus far, however, there has been no definitive report on its use for the treatment of symptomatic pseudoprogression. Here we report 2 cases of successful treatment wi...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Miyatake, Shin-Ichi, Furuse, Motomasa, Kawabata, Shinji, Maruyama, Takashi, Kumabe, Toshihiro, Kuroiwa, Toshihiko, Ono, Koji
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2013
Témata:
Case Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3661101/
https://ncbi.nlm.nih.gov/pubmed/23460324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/not020
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky